Vascular Biogenics Price on January 7, 2025
VBLTDelisted Stock | USD 0.28 0.01 3.45% |
If you're considering investing in Vascular Stock, it is important to understand the factors that can impact its price. As of today, the current price of Vascular Biogenics stands at 0.28, as last reported on the 23rd of January, with the highest price reaching 0.30 and the lowest price hitting 0.28 during the day. We have found nine technical indicators for Vascular Biogenics, which you can use to evaluate the volatility of the company. Please validate Vascular Biogenics' Market Facilitation Index of 0.02, day median price of 0.29, and Accumulation Distribution of 0.0667 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
Vascular Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Vascular |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
VBLT |
Based on monthly moving average Vascular Biogenics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vascular Biogenics by adding Vascular Biogenics to a well-diversified portfolio.
Related Headline
Hookipa Pharma Headline on 7th of January 2025
Poolbeg Pharma plc and HOOKIPA Pharma Inc. Update on Potenti... by globenewswire.com
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE...
Vascular Biogenics Valuation on January 7, 2025
It is possible to determine the worth of Vascular Biogenics on a given historical date. On January 7, 2025 Vascular was worth 0.29 at the beginning of the trading date compared to the closed value of 0.28. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vascular Biogenics stock. Still, in general, we apply an absolute valuation method to find Vascular Biogenics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vascular Biogenics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vascular Biogenics' related companies.
Open | High | Low | Close | Volume | |
01/23/2025 | 0.29 | 0.30 | 0.28 | 0.28 | 0.00 |
Backtest Vascular Biogenics | | | Vascular Biogenics History | | | Vascular Biogenics Valuation |
Vascular Biogenics Trading Date Momentum on January 7, 2025
Vascular Biogenics Fundamentals Correlations and Trends
By evaluating Vascular Biogenics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vascular Biogenics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vascular financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Vascular Biogenics Stock history
Vascular Biogenics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vascular is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vascular Biogenics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vascular Biogenics stock prices may prove useful in developing a viable investing in Vascular Biogenics
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modiin, Israel. Vascular Biogen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.
Vascular Biogenics Stock Technical Analysis
Vascular Biogenics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Vascular Biogenics Period Price Range
Low | January 23, 2025
| High |
0.00 | 0.00 |
Vascular Biogenics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Vascular Biogenics January 23, 2025 Market Strength
Market strength indicators help investors to evaluate how Vascular Biogenics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vascular Biogenics shares will generate the highest return on investment. By undertsting and applying Vascular Biogenics stock market strength indicators, traders can identify Vascular Biogenics entry and exit signals to maximize returns
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Vascular Stock
If you are still planning to invest in Vascular Biogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Biogenics' history and understand the potential risks before investing.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |